Skip to main content

Advertisement

Table 2 Treatment characteristics

From: Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis

Characteristics n (%)
Radiotherapy field   
 Whole pelvis and lower para-aortic lymphatics 4 4.4
 Whole pelvis and entire para-aortic lymphatics 86 95.6
Chemotherapy   
 None 44 48.9
 Concurrent chemotherapy 46 51.1
  Weekly cisplatin or carboplatin 24 26.6
  Cisplatin or carboplatin followed by 5-FU 22 24.5
Total dose to point A (Gy)   
 Median 70.2  
 Range (56–93)  
 Interquartile range (75th and 25th percentiles) 14.4 (80.4,66)  
Total dose to para-aortic lymphatics   
 Median 50.4  
 Range (45–60.4)  
 Interquartile range (75th and 25th percentiles) 3.6 (54, 50.4)  
Radiotherapy duration (days)   
 Median 69  
 Range (43–182)  
 Interquartile range (75th and 25th percentiles) 20 (80, 60)